PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to determine if extended-release dipyridamole + aspirin
[Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis,
Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to
placebo, in the presence of background antihypertensive therapy, in prevention of a second
stroke in patients who have recently suffered a stroke and therefore are at high risk of
suffering another one.
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Collaborators:
Bayer GlaxoSmithKline
Treatments:
Aspirin, Dipyridamole Drug Combination Clopidogrel Telmisartan Ticlopidine